# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016278
Filing Date
2023-05-11
Accepted
2023-05-11 07:30:55
Documents
66
Period of Report
2023-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 732959
2 |  | ex31-1.htm | EX-31.1 | 15691
3 |  | ex31-2.htm | EX-31.2 | 15520
4 |  | ex32.htm | EX-32 | 12262
| Complete submission text file | 0001493152-23-016278.txt |  | 4765970

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | abeo-20230331.xsd | EX-101.SCH | 33275
6 | XBRL CALCULATION FILE | abeo-20230331_cal.xml | EX-101.CAL | 59133
7 | XBRL DEFINITION FILE | abeo-20230331_def.xml | EX-101.DEF | 171542
8 | XBRL LABEL FILE | abeo-20230331_lab.xml | EX-101.LAB | 331460
9 | XBRL PRESENTATION FILE | abeo-20230331_pre.xml | EX-101.PRE | 265424
60 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 693150

Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 23908838
SIC: 2834 Pharmaceutical Preparations